Tinzaparin Provides Lower Lipid Profiles in Maintenance Hemodialysis Patients: A Cross-Sectional Observational Study

As a low-molecular-weight heparin, tinzaparin has effectively been used as an anticoagulant during hemodialysis sessions. However, the impact of different heparin types on dyslipidemia is still controversial. In our study, 434 chronic hemodialysis patients were evaluated. The mean age was 65 ± 13. F...

Full description

Saved in:
Bibliographic Details
Main Authors: Ming-Hsien Tsai, Yu-Wei Fang, Jyh-Gang Leu
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2014/486781
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555425133756416
author Ming-Hsien Tsai
Yu-Wei Fang
Jyh-Gang Leu
author_facet Ming-Hsien Tsai
Yu-Wei Fang
Jyh-Gang Leu
author_sort Ming-Hsien Tsai
collection DOAJ
description As a low-molecular-weight heparin, tinzaparin has effectively been used as an anticoagulant during hemodialysis sessions. However, the impact of different heparin types on dyslipidemia is still controversial. In our study, 434 chronic hemodialysis patients were evaluated. The mean age was 65 ± 13. Forty-eight patients (11%) and 386 patients (89%) were in the tinzaparin and unfractionated heparin (UFH) groups, respectively. Triglyceride had significant difference between the two groups (P=0.001) but total cholesterol, HDL, or LDL did not. In the univariate analysis, the triglyceride level was significantly associated with tinzaparin use [β: −39.9, 95% confidence interval (CI): −76.7 to −3.0], and this association remained following the multivariate analysis (β: −40.8, 95% CI: −75.1 to −6.5). The difference in serum total cholesterol level between tinzaparin and UFH became significant (β: −13, 95% CI: −24.5 to −1.56) after adjustment in the multivariate analysis. Moreover, in a subgroup analysis, male diabetic patients showed lower serum triglyceride levels with the use of tinzaparin, while older, nondiabetic, male patients showed significant advantages in total cholesterol levels with the use of tinzaparin. Based on our findings, tinzaparin shows a significant association with a lower lipid profile in patients with chronic hemodialysis when compared to UFH.
format Article
id doaj-art-69ed190601df487fb9b8e77f89e0dcc3
institution Kabale University
issn 2356-6140
1537-744X
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-69ed190601df487fb9b8e77f89e0dcc32025-02-03T05:48:19ZengWileyThe Scientific World Journal2356-61401537-744X2014-01-01201410.1155/2014/486781486781Tinzaparin Provides Lower Lipid Profiles in Maintenance Hemodialysis Patients: A Cross-Sectional Observational StudyMing-Hsien Tsai0Yu-Wei Fang1Jyh-Gang Leu2Division of Nephrology, Department of Internal Medicine, Shin-Kong Wu Ho-Su Memorial Hospital, No. 95 Wen-Chang Road, Shih-Lin District, Taipei 111, TaiwanDivision of Nephrology, Department of Internal Medicine, Shin-Kong Wu Ho-Su Memorial Hospital, No. 95 Wen-Chang Road, Shih-Lin District, Taipei 111, TaiwanDivision of Nephrology, Department of Internal Medicine, Shin-Kong Wu Ho-Su Memorial Hospital, No. 95 Wen-Chang Road, Shih-Lin District, Taipei 111, TaiwanAs a low-molecular-weight heparin, tinzaparin has effectively been used as an anticoagulant during hemodialysis sessions. However, the impact of different heparin types on dyslipidemia is still controversial. In our study, 434 chronic hemodialysis patients were evaluated. The mean age was 65 ± 13. Forty-eight patients (11%) and 386 patients (89%) were in the tinzaparin and unfractionated heparin (UFH) groups, respectively. Triglyceride had significant difference between the two groups (P=0.001) but total cholesterol, HDL, or LDL did not. In the univariate analysis, the triglyceride level was significantly associated with tinzaparin use [β: −39.9, 95% confidence interval (CI): −76.7 to −3.0], and this association remained following the multivariate analysis (β: −40.8, 95% CI: −75.1 to −6.5). The difference in serum total cholesterol level between tinzaparin and UFH became significant (β: −13, 95% CI: −24.5 to −1.56) after adjustment in the multivariate analysis. Moreover, in a subgroup analysis, male diabetic patients showed lower serum triglyceride levels with the use of tinzaparin, while older, nondiabetic, male patients showed significant advantages in total cholesterol levels with the use of tinzaparin. Based on our findings, tinzaparin shows a significant association with a lower lipid profile in patients with chronic hemodialysis when compared to UFH.http://dx.doi.org/10.1155/2014/486781
spellingShingle Ming-Hsien Tsai
Yu-Wei Fang
Jyh-Gang Leu
Tinzaparin Provides Lower Lipid Profiles in Maintenance Hemodialysis Patients: A Cross-Sectional Observational Study
The Scientific World Journal
title Tinzaparin Provides Lower Lipid Profiles in Maintenance Hemodialysis Patients: A Cross-Sectional Observational Study
title_full Tinzaparin Provides Lower Lipid Profiles in Maintenance Hemodialysis Patients: A Cross-Sectional Observational Study
title_fullStr Tinzaparin Provides Lower Lipid Profiles in Maintenance Hemodialysis Patients: A Cross-Sectional Observational Study
title_full_unstemmed Tinzaparin Provides Lower Lipid Profiles in Maintenance Hemodialysis Patients: A Cross-Sectional Observational Study
title_short Tinzaparin Provides Lower Lipid Profiles in Maintenance Hemodialysis Patients: A Cross-Sectional Observational Study
title_sort tinzaparin provides lower lipid profiles in maintenance hemodialysis patients a cross sectional observational study
url http://dx.doi.org/10.1155/2014/486781
work_keys_str_mv AT minghsientsai tinzaparinprovideslowerlipidprofilesinmaintenancehemodialysispatientsacrosssectionalobservationalstudy
AT yuweifang tinzaparinprovideslowerlipidprofilesinmaintenancehemodialysispatientsacrosssectionalobservationalstudy
AT jyhgangleu tinzaparinprovideslowerlipidprofilesinmaintenancehemodialysispatientsacrosssectionalobservationalstudy